These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 12108901)

  • 1. The role of docetaxel in the management of squamous cell cancer of the head and neck.
    Glisson BS
    Oncology (Williston Park); 2002 Jun; 16(6 Suppl 6):83-7. PubMed ID: 12108901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Taxoids in head and neck cancer: the American approach.
    Forastiere AA
    Acta Otorhinolaryngol Belg; 1999; 53(3):253-7. PubMed ID: 10635404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advanced head and neck cancer and clinical experience of an effective new agent: docetaxel.
    Schöffski P; Weihkopf T; Ganser A
    Anticancer Res; 1998; 18(6B):4751-6. PubMed ID: 9891552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Docetaxel in squamous cell cancer of the head and neck.
    Posner MR
    Anticancer Drugs; 2001 Feb; 12 Suppl 1():S21-4. PubMed ID: 11340900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Docetaxel and radiation as combined-modality therapy.
    Kim ES; Khuri FR
    Oncology (Williston Park); 2002 Jun; 16(6 Suppl 6):97-105. PubMed ID: 12108904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integration of taxanes into primary chemotherapy for squamous cell carcinoma of the head and neck: promise fulfilled?
    Brockstein B
    Curr Opin Oncol; 2000 May; 12(3):221-8. PubMed ID: 10841194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concurrent weekly docetaxel and concomitant boost radiation therapy in the treatment of locally advanced squamous cell cancer of the head and neck.
    Tishler RB; Posner MR; Norris CM; Mahadevan A; Sullivan C; Goguen L; Wirth LJ; Costello R; Case M; Stowell S; Sammartino D; Busse PM; Haddad RI
    Int J Radiat Oncol Biol Phys; 2006 Jul; 65(4):1036-44. PubMed ID: 16682134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Phase I/II trial of concurrent docetaxel and radiation after induction chemotherapy in patients with poor prognosis squamous cell carcinoma of the head and neck.
    Tishler RB; Norris CM; Colevas AD; Lamb CC; Karp D; Busse PM; Nixon A; Frankenthaler R; Lake-Willcutt B; Costello R; Case M; Posner MR
    Cancer; 2002 Oct; 95(7):1472-81. PubMed ID: 12237916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The chemotherapy of head and neck cancer.
    De Mulder PH
    Acta Otorhinolaryngol Belg; 1999; 53(3):247-52. PubMed ID: 10635403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Docetaxel in head and neck cancer: a review.
    Colevas AD; Posner MR
    Am J Clin Oncol; 1998 Oct; 21(5):482-6. PubMed ID: 9781605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Docetaxel for locally advanced or metastatic non-small-cell lung cancer. Current data and future directions as front-line therapy.
    Khuri FR
    Oncology (Williston Park); 2002 Jun; 16(6 Suppl 6):53-62. PubMed ID: 12108898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The current status of docetaxel in solid tumors. An M. D. Anderson Cancer Center Review.
    Hong WK
    Oncology (Williston Park); 2002 Jun; 16(6 Suppl 6):9-15. PubMed ID: 12108903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Docetaxel in the integrated management of prostate cancer. Current applications and future promise.
    Logothetis CJ
    Oncology (Williston Park); 2002 Jun; 16(6 Suppl 6):63-72. PubMed ID: 12108899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of docetaxel (Taxotere) as a single agent or in combination before local treatment of non-small cell lung cancer.
    Harper P
    Semin Oncol; 1997 Aug; 24(4 Suppl 14):S14-30-S14-32. PubMed ID: 9335522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on the taxoids and other new agents in head and neck cancer therapy.
    Schrijvers D; Vermorken JB
    Curr Opin Oncol; 1998 May; 10(3):233-41. PubMed ID: 9619360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Docetaxel in the treatment of non-small cell lung cancer: review of single-agent trials.
    Fossella FV
    Semin Oncol; 1999 Oct; 26(5 Suppl 16):17-23; discussion 41-2. PubMed ID: 10585004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Docetaxel for gastric and esophageal carcinomas.
    Ajani JA
    Oncology (Williston Park); 2002 Jun; 16(6 Suppl 6):89-96. PubMed ID: 12108902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of docetaxel (Taxotere) in neoadjuvant chemotherapy of breast cancer.
    Costa SD; von Minckwitz G; Raab G; Blohmer JU; Dresel V; Eidtmann H; Hilfrich J; Jackisch C; Merkle E; Gademann G; Kaufmann M
    Semin Oncol; 1999 Jun; 26(3 Suppl 9):24-31. PubMed ID: 10426456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Docetaxel said to be highly effective and well tolerated in advanced head and neck cancer.
    Oncology (Williston Park); 1996 Mar; 10(3):422. PubMed ID: 8820455
    [No Abstract]   [Full Text] [Related]  

  • 20. [Docetaxel: a new weapon in the treatment of head and neck tumors].
    Melano M
    Tumori; 2001; 87(6):A9-10. PubMed ID: 11995709
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.